A three-country comparison of psychotropic medication prevalence in youth
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The study aims to compare cross-national prevalence of psychotropic medication use in youth. METHODS: A population-based analysis of psychotropic medication use based on administrative claims data for the year 2000 was undertaken for insured enrollees from 3 countries in relation to age group (0-4, 5-9, 10-14, and 15-19), gender, drug subclass pattern and concomitant use. The data include insured youth aged 0-19 in the year 2000 from the Netherlands (n = 110,944), Germany (n = 356,520) and the United States (n = 127,157). RESULTS: The annual prevalence of any psychotropic medication in youth was significantly greater in the US (6.7%) than in the Netherlands (2.9%) and in Germany (2.0%). Antidepressant and stimulant prevalence were 3 or more times greater in the US than in the Netherlands and Germany, while antipsychotic prevalence was 1.5-2.2 times greater. The atypical antipsychotic subclass represented only 5% of antipsychotic use in Germany, but 48% in the Netherlands and 66% in the US. The less commonly used drugs e.g. alpha agonists, lithium and antiparkinsonian agents generally followed the ranking of US>Dutch>German youth with very rare (less than 0.05%) use in Dutch and German youth. Though rarely used, anxiolytics were twice as common in Dutch as in US and German youth. Prescription hypnotics were half as common as anxiolytics in Dutch and US youth and were very uncommon in German youth. Concomitant drug use applied to 19.2% of US youth which was more than double the Dutch use and three times that of German youth. CONCLUSION: Prominent differences in psychotropic medication treatment patterns exist between youth in the US and Western Europe and within Western Europe. Differences in policies regarding direct to consumer drug advertising, government regulatory restrictions, reimbursement policies, diagnostic classification systems, and cultural beliefs regarding the role of medication for emotional and behavioral treatment are likely to account for these differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The rates of increase of pediatric psychotropic drug prescription in the US are alarming (30,34).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [34]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The duration of stimulant drug treatment has also greatly increased (34)(35)(36).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Social Transformation of American Medicine
Leavitt, J. W., & Starr, P. (1984) · The American Historical Review · doi:10.2307/1862729 · Cited by 3,247
Basic and Clinical Biostatistics,
(2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00360-0 · Cited by 1,809
McPherson, K., Wennberg, J. E., Hovind, O. B., & Clifford, P. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211183072104 · Cited by 822
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
The Social Transformation of American Medicine
MUELLER, C. B. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390120071024 · Cited by 614
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J., Sergeant, J., Taylor, E., Sonuga-Barke, E., Jensen, P., & Cantwell, D. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11450-7 · Cited by 601
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & Cantwell, D. P. (2001) · Attention Deficit Hyperactivity Disorders · doi:10.4324/9781315054315-2 · Cited by 572
Psychotropic Practice Patterns for Youth: A 10-Year Perspective
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.157.1.17 · Cited by 526
Self-citationBasic and Clinical Biostatistics
Rosenbaum, S. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460050106033 · Cited by 415
Pharmacoepidemiology and Drug Safety
Mucklow, J. C. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.804.846-b · Cited by 296
Research works printed but not linked: 2
- Chiang CL Standard error of the age-adjusted death rate US Dept HEW: Vital Statistics Special Reports 1961 47 271 285
- Zito JM Safer DJ Fegert JM Tobi H Janhsen K Glaeske G Menis M Ryu J Neuroleptic prevalence for youths: a multi-national comparison Poster presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry Toronto 2005
Cited by
Items 101–200 of 223
Courtabessis, É., Pupier, F., Sürig, L., Picot, M., Nogué, E., Macioce, V., Stein, E. M., & Purper‐Ouakil, D. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1061-4 · Cited by 16
Uses and misuses of treatments for ADHD. The second Birgit Olsson lecture
Taylor, E. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2013.804118 · Cited by 16
Psychostimulant Prescription for ADHD in New South Wales: A Longitudinal Perspective
Prosser, B. J., Lambert, M. C., & Reid, R. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714553053 · Cited by 16
Dubrall, D., Fekete, S., Leitzen, S., Paschke, L. M., Romanos, M., Schmid, M., Gerlach, M., & Sachs, B. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00664-z · Cited by 15
Bose‐Brill, S., Xing, J., Barnette, D. J., & Hanks, C. D. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s130247 · Cited by 15
Schübert, I., & Lehmkuhl, G. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.269 · Cited by 15
Prescription of Psychiatric Medications and Polypharmacy in the LAMS Cohort
Kowatch, R. A., Youngstrom, E. A., Horwitz, S. M., Demeter, C., Fristad, M. A., Birmaher, B. B., Axelson, D., Ryan, N. D., Frazier, T. W., Arnold, L. E., et al. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200507 · Cited by 14
Song, I., Lee, M. S., Lee, E., & Shin, J. (2017) · Asia-Pacific Psychiatry · doi:10.1111/appy.12289 · Cited by 13
Kölch, M. G., Allroggen, M., & Fegert, J. M. (2009) · Der Nervenarzt · doi:10.1007/s00115-009-2727-z · Cited by 13
Self-citationSteffenak, A. K. M., Nordström, G. M., Hartz, I., & Wilde‐Larsson, B. (2015) · Journal of Clinical Nursing · doi:10.1111/jocn.12716 · Cited by 13
The Association between Medication for Attention-Deficit/Hyperactivity Disorder and Cancer
Steinhausen, H., & Helenius, D. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0050 · Cited by 13
Leckman, J. F. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345543 · Cited by 12
Comparison of psychotropic medication use in the Baltic countries
Harro, J., Aadamsoo, K., Rootslane, L., Laius, O., O’Leary, A., Adomaitienė, V., Kupca, B., Lehtmets, A., Navickas, A., Rancāns, E., et al. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1707283 · Cited by 12
Bethancourt, J. A., Vásquez, C. E., & Britton, G. B. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.080 · Cited by 12
O’Sullivan, K., Boland, F., Reulbach, U., Motterlini, N., Kelly, D., Bennett, K., & Fahey, T. P. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0436-2 · Cited by 12
Psychotropic drugs and paediatrics: a critical need for more clinical trials
Tishler, C. L., & Reiss, N. S. (2011) · Journal of Medical Ethics · doi:10.1136/medethics-2011-100003 · Cited by 12
The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
Oerbeck, B., Øvergaard, K. R., Hjellvik, V., Lien, L., & Bramness, J. G. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0123 · Cited by 12
van Wattum, P. J., Fabius, C., Roos, C. R., Smith, C. C., & Johnson, T. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0014 · Cited by 12
Schmäl, C., Becker, K., Berg, R., Brünger, M., Lehmkuhl, G., Oehler, K.-U., Ruppert, T., Staudter, C., Trott, G., & Dittmann, R. (2014) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000322 · Cited by 11
Tanielian, M., Antoun, J., Sidani, M., Halabi, A., Hoballah, M. M., Hawatian, K., & Assaf, G. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01707-w · Cited by 11
Metabolic and Endocrine Side Effects of Atypical Antipsychotic Drugs in Children and Adolescents
Çelik, G. G., Tahiroğlu, A. Y., & Avcı, A. (2011) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.63696 · Cited by 11
Akıncıgil, A., Mackie, T. I., Cook, S., Hilt, R. J., & Crystal, S. (2020) · Health Services Research · doi:10.1111/1475-6773.13297 · Cited by 11
Hollingworth, S., Duhig, M., Hall, W., & Scott, J. G. (2013) · Australasian Psychiatry · doi:10.1177/1039856213497809 · Cited by 11
Sun, J. W., Young, J. G., Sarvet, A. L., Bailey, L. C., Heerman, W. J., Janicke, D. M., Lin, P. D., Toh, S., & Block, J. P. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.6484 · Cited by 10
Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain
Murphy, A. L., Gardner, D. M., Kisely, S. R., Cooke, C., Kutcher, S., & Hughes, J. R. (2013) · ISRN Obesity · doi:10.1155/2013/390130 · Cited by 10
The Use of Sleep Medication in Youth Residential Care
Oerbeck, B., Øvergaard, K. R., Hjellvik, V., Bramness, J. G., Hansen, B. H., & Lien, L. (2020) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0172 · Cited by 9
Use of Antipsychotic Medications in Pediatric and Young Adult Populations: Future Research Needs
Christian, R. B., Gaynes, B. N., Saavedra, L. M., Sheitman, B., Wines, R., Jonas, D. E., Viswanathan, M., Ellis, A. R., Woodell, C., & Carey, T. S. (2015) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000460619.10429.4c · Cited by 9
Drug utilization patterns of antidepressants in Federal Neuro-Psychiatric Hospital Lagos, Nigeria
Kehinde, O., Anyika, E. N., & Abah, I. O. (2017) · Journal of Hospital Administration · doi:10.5430/jha.v6n5p12 · Cited by 9
The use of prn medication in a child and adolescent mental health inpatient service in France
Winterfeld, U., Heuzey, M. L., Acquaviva, É., Mouren, M., Brion, F., & Bourdon, O. (2009) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500902849987 · Cited by 9
Ansermot, N., Jordanov, V., Smogur, M., Holzer, L., & Eap, C. B. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0054 · Cited by 8
Smoking during pregnancy and fetal brain development
Ekblad, M. O. (2013) · UTUPub (University of Turku) · Cited by 8
Psychopharmaka im Kindes- und Jugendalter
Libal, G., & Schmeck, K. (2009) · Therapeutische Umschau · doi:10.1024/0040-5930.66.6.467 · Cited by 7
Bilsky, S. A., Blumenthal, H., Ramadan, B., Lewis, S., & Leen‐Feldner, E. W. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0010 · Cited by 6
Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population
Pesiou, S., Barcelo, R., Papazisis, G., Torres, F., & Pontes, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1348887 · Cited by 6
Consumer Advertisements for Psychostimulants in the United States
Lacasse, J. R., & Leo, J. (2009) · The Psychiatric times · Cited by 6
Childhood predictors of antipsychotic use among young people in Finland
Gyllenberg, D., Sourander, A., Helenius, H. Y. M., Sillanmäki, L. H., Huttunen, J., Piha, J., Kumpulainen, K., Tamminen, T., Moilanen, I. K., & Almqvist, F. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3265 · Cited by 6
Gentile, S. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.908849 · Cited by 6
Engelke, C., Lange‐Asschenfeldt, C., Peter, S., Kahl, K. G., Frasch, K., Larsen, J. I., Bickel, G. G., Bork, B., Jacobsen, B. A., Wallenstein-Jensen, S. O., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.11.004 · Cited by 6
Mamdani, M., & Wilby, K. J. (2013) · Journal of Health Specialties · doi:10.4103/1658-600x.114689 · Cited by 6
A European perspective on paedo‐psychiatric pharmacoepidemiology
Steinhausen, H. (2013) · World Psychiatry · doi:10.1002/wps.20034 · Cited by 5
Sommer, A., Grochowska, K., Grothus, S., Claus, B. B., Stahlschmidt, L., & Wager, J. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.02.030 · Cited by 5
Attention-Deficit/Hyperactivity Disorder
DuPaul, G. J., Pollack, B., & Pinho, T. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-57196-6_20 · Cited by 5
The addictive process of opioids: current and novel interventions in opioid use disorder
Duerksen, J. M., Ramjiawan, M., Witt, J. C., Fitzpatrick-Wong, S. C., Tappia, P. S., Ramjiawan, B., Mansouri, B., Sareen, J., & Knight, E. (2025) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0281 · Cited by 5
Cross-country variation in medicines use; a pharmaceutical system perspective
Hoebert, J. M. (2013) · Utrecht University Repository (Utrecht University) · Cited by 5
Hebebrand, J., Blanz, B., Herpertz‐Dahlmann, B., & Lehmkuhl, G. (2012) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000163 · Cited by 5
Shapiro, D. I., Grattan, R. E., Laquidara, J. R., Wadell, P. M., Suk, R., Muro, K., Shickman, R., Salmonsen, J., Tryon, V. L., Lesh, T. A., et al. (2026) · Early Intervention in Psychiatry · doi:10.1111/eip.70120 · Cited by 4
Conlan, K., McGrath, J., Teeling, M., MacAvin, M. J., Bennett, K., & Gallagher, L. (2021) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2021.7 · Cited by 4
Sahin, S., Erdman, A. L., Loewen, A., Miller, S. M., Jones, J. C., Chung, J. S., Janosky, J. J., & Ulman, S. M. (2024) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.11356 · Cited by 4
Pharmacoepidemiology of Psychotropic Medications in Youth
Safer, D. J., & ZITO, J. M. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch2 · Cited by 4
Self-citationEffectiveness and Tolerability of Aripiprazole in a Real-World Outpatient Population of Youth
Bildik, T., Özbaran, N. B., Köse, S., & Cetin, S. K. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120703061927 · Cited by 4
Boulton, E. (2020) · UWE Research Repository (UWE Bristol) · Cited by 4
Direct‐to‐consumer advertising and the advancement of the quadruple aim: A narrative review
Khokhar, B., Weathers, S., & Mattingly, T. J. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1599 · Cited by 3
Psychotropic drugs and their impact on the treatment of paediatric dental patients
Hajishengallis, E. (2013) · European Archives of Paediatric Dentistry · doi:10.1007/s40368-013-0053-4 · Cited by 3
Joubert, L., Burger, J. R., Truter, I., Lubbe, M. S., & Cockeran, M. (2018) · Health SA Gesondheid · doi:10.4102/hsag.v23i0.1084 · Cited by 3
Attention-Deficit/Hyperactivity Disorder in Young Males: The Medicalization of Boyhood?
Whitley, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-86320-3_4 · Cited by 3
Atypical antipsychotics for treatment of Tourette syndrome
Kalari, V. K., Morrison, P. E., & Budman, C. L. (2022) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.12.002 · Cited by 3
Lacasse, J. R., Dunleavy, D. J., & Hughes, S. (2021) · Child and Adolescent Social Work Journal · doi:10.1007/s10560-020-00731-y · Cited by 3
Driot, D., Vergès, Y., Birebent, J., Grosclaude, P., Delpierre, C., Bugat, M.-È. R., & Dupouy, J. (2023) · La Presse Médicale Open · doi:10.1016/j.lpmope.2023.100042 · Cited by 2
Karjouh, K., Azzaoui, F.-Z., Ahami, A. O. T., & Boulbaroud, S. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.31.133.13425 · Cited by 2
Alpha agonists for the treatment of Tourette syndrome
Cothros, N., & Pringsheim, T. M. (2022) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.12.003 · Cited by 2
Safety of Psychotropic Drugs in Children and Adolescents
Kaguelidou, F., & Acquaviva, É. (2015) · Springer eBooks · doi:10.1007/978-3-319-24741-0_13 · Cited by 2
Koopmann‐Holm, B. (2013) · Scholar Commons (Santa Clara University) · Cited by 2
Kölch, M. G., Fegert, J. M., & Plener, P. L. (2012) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-012-2716-3 · Cited by 2
Self-citationKnopf, H. C. (2017) · Public Health Forum · doi:10.1515/pubhef-2017-0019 · Cited by 2
Calleja, N. G., & Dadah, A. M. (2018) · The Family Journal · doi:10.1177/1066480717752899 · Cited by 2
Meek, F. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-24006 · Cited by 2
Listik, E., & Listik, M. (2020) · medRxiv · doi:10.1101/2020.10.17.20214437 · Cited by 2
Trends in the Use of Antipsychotics for Off-Label Indications: Clinical and Ethical Considerations
Siddique, M. I., Ahmad, S., & khan, A. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3273 · Cited by 1
Jaramillo-González, L. E., & Díaz, J. (2011) · Revista Colombiana de Ciencias Químico Farmacéuticas · Cited by 1
Communicating the science of IGCP 591 to the public
Lewandowski, K. (2014) · GFF · doi:10.1080/11035897.2014.898330 · Cited by 1
Pharmacoepidemiology of Antipsychotic Use in Canadian Children and Adolescents
Ortega, I., & Pringsheim, T. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800016-8.00002-7 · Cited by 1
Pediatric Psychopharmacology: Perspectives from Low Resource Countries
Konar, D., & Balachander, S. (2016) · Springer eBooks · doi:10.1007/978-81-322-3619-1_17 · Cited by 1
Dahl, L. J., Chartier, M., Fransoo, R., & Tefft, B. M. (2016) · PubMed Central · Cited by 1
Singh, N. N., Singh, A. N. A., Lancioni, G. E., & Adkins, A. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_59 · Cited by 1
Drug-Induced Movement Disorders in Children
Singer, H. S., Mink, J. W., Gilbert, D. L., & Jankovic, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820552-5.00015-2 · Cited by 1
Hawker, P. J., Bellamy, J., McHugh, C. M., Wong, T. Y., Williams, K. J., WOOD, A. G., Anderson, V. A., Tonge, B. J., Ward, P. B., Sciberras, E., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073893 · Cited by 1
Dinh, A., El‐Den, S., Collins, J. C., Hamilton, B., Janiszewski, C. M. S., Fowler, D., & O’Reilly, C. L. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0140 · Cited by 1
Centeno, G. A. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
1976, H. Z. (2011) · Skemman · Cited by 1
Mayer, J. (2011) · FreiDok plus (Universitätsbibliothek Freiburg) · Cited by 1
Deacutis, M. (2012) · St Andrews Research Repository (St Andrews Research Repository)
Wong, I. C. K., & Hsia, Y. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3859-9
Les psychotropes en pédopsychiatrie : comment les utiliser ? Quels référentiels ?
Purper‐Ouakil, D. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.09.241
Escalas y cuestionarios pragmáticos en psicofarmacología pediátrica: ¿estamos haciendo lo correcto?
Coghill, D. (2011) · Psiquiatría Biológica · doi:10.1016/j.psiq.2011.10.001
Is There A Role For “Older” Agents in Child Psychopharmacology?
CARREY, N. J. (2009) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2009.14.3.1
Steffenak, M., & Steffenak, A. K. M. (2014)
Miric, A. (2015) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Finding Balance: School-Based Yoga Programs for the Prevention and Reduction of Anxiety
Aaron, J. D. (2011) · JMU Scholoraly Commons (James Madison University)
Li, H., Kehoe, W. A., Woelfel, J. A., Catania, P. N., Boyce, E. G., Amaral, M. M., & Cituk, J. (2018) · Scholarly Commons (University of the Pacific)
Klora, M. (2018) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/4308
Caneja, M. C. M. D. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Gesundheitsökonomische Analysen von Versorgungsleitlinien anhand von GKV-Routinedaten
Neubauer, S. (2019) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/4786
Patterns of Antidepressant Prescriptions for the Treatment of Depression: A Scoping ReviewPreprint
Marasine, N. R., Sankhi, S., Lamichhane, R., & Dangi, N. B. (2020) · Research Square · doi:10.21203/rs.3.rs-65197/v1
Antidepressant usage by South African children and adolescents: A drug utilisation review
Rooyen, V., & Jacobus, C. (2013)
Metadata
- Authors
- Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C.
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- University of Groningen (NL)
- University of Bremen (DE)
- Corresponding author
- Zito, Julie M
- Venue
- Child and Adolescent Psychiatry and Mental Health
- Published
- 2008-09-25
- Volume
- 2
- Issue
- 1
- Pages
- 26-26
- ISSN
- 1753-2000 (ISSN-L)
- PMC
- PMC2569908
- OpenAlex
- W1996815465
- Cited by
- 201
- References
- 46
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 13 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 7 · 2017: 13 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 25 · 2012: 21
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Child and Adolescent Psychiatry and Mental Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- psychotropic drugs, youth, cross-national comparison, antidepressants, stimulants, antipsychotic drugs, atypical antipsychotics, anxiolytics, concomitant drug use, drug use prevalence, health policy, Netherlands, Germany, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.